8-K - CNS Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February

Management Change

9.01

. Financial Statements and Exhibits. (d) Exhibits. No. Description 10.1 Employment Agreement between Lynne Kelley and CNS Pharmaceuticals, Inc. dated February 2

Exhibits Only

Exhibits (3)

10.1

EMPLOYMENT AGREEMENT BETWEEN LYNNE KELLEY AND CNS PHARMACEUTICALS, INC.

10.2

SEPARATION AND SEVERANCE AGREEMENT BETWEEN SANDRA SILBERMAN AND CNS PHARMACEUTICALS, INC.

8-K

FORM 8-K